Researchers identify potential new genetic target for cancer drugs
Drug Discovery World
JULY 25, 2024
The team also uncovered a link between certain disruptive BAP1 variants and higher levels of IGF-1, a hormone and growth factor. The findings, published in Nature Genetics , are freely available so that they can be immediately used by doctors to help diagnose patients and choose the most effective therapies for them.
52 
Let's personalize your content